Data

Risperidone in First Episode Schizophrenia - Baseline, Melbourne Neuropsychiatry Centre

The University of Melbourne
Professor Christos Pantelis (Owned by)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft.title=Risperidone in First Episode Schizophrenia - Baseline, Melbourne Neuropsychiatry Centre&rft.publisher=The University of Melbourne&rft.description=This aim of this project was to use H2O15 PET technique to compare cerebral activation in patients with first-episode schizophrenia and normal control subjects during cognitive activation using the Stroop task. Patients were assessed while drug-naïve and then re-examined when stabilised on risperidone or haloperidol. Twenty drug naïve patients with recent onset schizophrenia or schizophreniform psychosis (from EPPIC, Orygen Youth Health), and ten normal healthy subjects (matched to the patients group) were recruited. Participants completed baseline and 8-12 week follow-up scans (PET and MRI). After baseline scans, patients will be randomised to treatment with either risperidone or haloperidol. This project refers to the baseline scans. Time period: 1997-1999&rft.creator=Professor Christos Pantelis&rft.date=2013&rft_subject=NEUROSCIENCES&rft_subject=MEDICAL AND HEALTH SCIENCES&rft.type=dataset&rft.language=English Access the data

Please use the contact information below to request access to this data.

Contact Information



Cite Saved to MyRDA Save to MyRDA

Access:

Other view details

The owner of this data collection may provide access to this data collection by negotiation. You could be required to indicate your intended use of the data, to meet any costs associated with providing you with the data, and to fulfill other terms and conditions as determined by the data owner / manager. Use of the data may also be subject to legal, ethical and commercial restrictions, requiring further permission from other individuals or groups, including ethics committees, project steering groups, and research participants.

Full description

This aim of this project was to use H2O15 PET technique to compare cerebral activation in patients with first-episode schizophrenia and normal control subjects during cognitive activation using the Stroop task. Patients were assessed while drug-naïve and then re-examined when stabilised on risperidone or haloperidol. Twenty drug naïve patients with recent onset schizophrenia or schizophreniform psychosis (from EPPIC, Orygen Youth Health), and ten normal healthy subjects (matched to the patients group) were recruited. Participants completed baseline and 8-12 week follow-up scans (PET and MRI). After baseline scans, patients will be randomised to treatment with either risperidone or haloperidol. This project refers to the baseline scans. Time period: 1997-1999

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related People

Subjects
Medical and Health Sciences | Neurosciences |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Similar data you may be interested in: